CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: bromuconazole
Accession: CHEBI:81900
browse the term
Definition: A member of the class of oxolanes carrying 1,2,4-triazol-ylmethyl and 2,4-dichlorophenyl substituents at position 2 as well as a bromo substituent at position 4. A foliar applied conazole fungicide for a range of crops including cereals, fruit, vegetables and vines.
Synonyms: exact_synonym: 2,5-anhydro-4-bromo-1,3,4-trideoxy-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pentitol
related_synonym: 1-((4-Bromo-2-(2,4-dichlorophenyl)tetrahydro-2-furanyl)methyl)-1H-1,2,4-triazole; Formula=C13H12BrCl2N3O; InChI=1S/C13H12BrCl2N3O/c14-9-4-13(20-5-9,6-19-8-17-7-18-19)11-2-1-10(15)3-12(11)16/h1-3,7-9H,4-6H2; InChIKey=HJJVPARKXDDIQD-UHFFFAOYSA-N; SMILES=N1(N=CN=C1)CC2(CC(CO2)Br)C=3C(=CC(=CC3)Cl)Cl
xref: AGR:IND43838427; CAS:116255-48-2; KEGG:C18704
xref_mesh: MESH:C573694
xref: PMID:17573638; PMID:19517438; PMID:22532344; PMID:23616354; PPDB:97; Patent:EP258161; Pesticides:bromuconazole; Reaxys:8393967
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression
EXP
bromuconazole results in decreased expression of ABCC2 mRNA
CTD
PMID:33789219
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Ar
androgen receptor
multiple interactions
ISO
bromuconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]
CTD
PMID:33049310
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Bax
BCL2 associated X, apoptosis regulator
increases expression
EXP
bromuconazole results in increased expression of BAX mRNA
CTD
PMID:36370923
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
decreases expression
EXP
bromuconazole results in decreased expression of BCL2 mRNA
CTD
PMID:36370923
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
increases activity
EXP
bromuconazole results in increased activity of CASP3 mRNA
CTD
PMID:36370923
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cldn1
claudin 1
affects expression
EXP
bromuconazole affects the expression of CLDN1 mRNA
CTD
PMID:33789219
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Crot
carnitine O-octanoyltransferase
decreases expression
EXP
bromuconazole results in decreased expression of CROT mRNA
CTD
PMID:33789219
NCBI chr 4:25,068,270...25,133,111
Ensembl chr 4:25,080,587...25,133,109
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
EXP
bromuconazole results in increased expression of CYP1A2 mRNA
CTD
PMID:33789219
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
increases expression
EXP
bromuconazole results in increased expression of CYP27A1 mRNA
CTD
PMID:33789219
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
decreases expression increases expression
EXP
bromuconazole results in decreased expression of CYP2B1 bromuconazole results in increased expression of CYP2B1 mRNA
CTD
PMID:28532222 PMID:33789219
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
increases expression
EXP
bromuconazole results in increased expression of CYP2B2 mRNA
CTD
PMID:33789219
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
increases expression
EXP
bromuconazole results in increased expression of CYP2C11 mRNA
CTD
PMID:33789219
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
increases expression
EXP
bromuconazole results in increased expression of CYP2C6 mRNA
CTD
PMID:33789219
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
bromuconazole results in increased expression of CYP3A23-3A1
CTD
PMID:28532222
NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
increases expression
EXP
bromuconazole results in increased expression of CYP3A9 mRNA
CTD
PMID:33789219
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
decreases expression
EXP
bromuconazole results in decreased expression of CYP8B1 mRNA
CTD
PMID:33789219
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Esr1
estrogen receptor 1
multiple interactions
ISO
bromuconazole binds to and results in increased activity of ESR1 protein
CTD
PMID:33049310
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Fabp7
fatty acid binding protein 7
decreases expression
EXP
bromuconazole results in decreased expression of FABP7 mRNA
CTD
PMID:33789219
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
G
Fam13a
family with sequence similarity 13, member A
affects expression
EXP
bromuconazole affects the expression of FAM13A mRNA
CTD
PMID:33789219
NCBI chr 4:88,056,521...88,155,782
Ensembl chr 4:88,058,403...88,155,860
G
Gckr
glucokinase regulator
decreases expression
EXP
bromuconazole results in decreased expression of GCKR mRNA
CTD
PMID:33789219
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
G
Gfra3
GDNF family receptor alpha 3
increases expression
EXP
bromuconazole results in increased expression of GFRA3 mRNA
CTD
PMID:33789219
NCBI chr18:26,297,828...26,326,105
Ensembl chr18:26,297,829...26,326,105
G
Got1
glutamic-oxaloacetic transaminase 1
increases expression
EXP
bromuconazole results in increased expression of GOT1 protein
CTD
PMID:33789219
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
G
Gpam
glycerol-3-phosphate acyltransferase, mitochondrial
increases expression
EXP
bromuconazole results in increased expression of GPAM mRNA
CTD
PMID:33789219
NCBI chr 1:254,106,323...254,170,755
Ensembl chr 1:254,106,331...254,142,639
G
Gpr39
G protein-coupled receptor 39
increases expression
EXP
bromuconazole results in increased expression of GPR39 mRNA
CTD
PMID:33789219
NCBI chr13:37,115,258...37,327,312
Ensembl chr13:37,115,102...37,328,267
G
Hacl1
2-hydroxyacyl-CoA lyase 1
increases expression
EXP
bromuconazole results in increased expression of HACL1 mRNA
CTD
PMID:33789219
NCBI chr16:6,826,881...6,863,027
Ensembl chr16:6,824,906...6,863,027
G
Hnf1a
HNF1 homeobox A
increases expression
EXP
bromuconazole results in increased expression of HNF1A mRNA
CTD
PMID:33789219
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
increases expression
EXP
bromuconazole results in increased expression of HPRT1 mRNA
CTD
PMID:33789219
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
decreases expression
EXP
bromuconazole results in decreased expression of HSD17B2 mRNA
CTD
PMID:33789219
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
decreases expression
EXP
bromuconazole results in decreased expression of HSP90AA1 mRNA
CTD
PMID:33789219
NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268
G
Ier5
immediate early response 5
increases expression
EXP
bromuconazole results in increased expression of IER5 mRNA
CTD
PMID:33789219
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
decreases expression
EXP
bromuconazole results in decreased expression of IFIT3 mRNA
CTD
PMID:33789219
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Insig1
insulin induced gene 1
increases expression
EXP
bromuconazole results in increased expression of INSIG1 mRNA
CTD
PMID:33789219
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Insig2
insulin induced gene 2
increases expression
EXP
bromuconazole results in increased expression of INSIG2 mRNA
CTD
PMID:33789219
NCBI chr13:32,472,390...32,500,139
Ensembl chr13:32,473,742...32,494,923
G
Isg15
ISG15 ubiquitin-like modifier
decreases expression
EXP
bromuconazole results in decreased expression of ISG15 mRNA
CTD
PMID:33789219
NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
G
Jade1
jade family PHD finger 1
decreases expression
EXP
bromuconazole results in decreased expression of JADE1 mRNA
CTD
PMID:33789219
NCBI chr 2:124,543,233...124,596,361
Ensembl chr 2:124,543,286...124,596,354
G
Kalrn
kalirin, RhoGEF kinase
increases expression
EXP
bromuconazole results in increased expression of KALRN mRNA
CTD
PMID:33789219
NCBI chr11:66,198,155...66,803,166
Ensembl chr11:66,198,173...66,797,610
G
Kynu
kynureninase
decreases expression
EXP
bromuconazole results in decreased expression of KYNU mRNA
CTD
PMID:33789219
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
Lgalsl
galectin-like
affects expression
EXP
bromuconazole affects the expression of LGALSL mRNA
CTD
PMID:33789219
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
G
Lpl
lipoprotein lipase
decreases expression
EXP
bromuconazole results in decreased expression of LPL mRNA
CTD
PMID:33789219
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Manea
mannosidase, endo-alpha
affects expression
EXP
bromuconazole affects the expression of MANEA mRNA
CTD
PMID:33789219
NCBI chr 5:40,196,373...40,218,540
Ensembl chr 5:40,196,396...40,218,459
G
Mx2
MX dynamin like GTPase 2
decreases expression
EXP
bromuconazole results in decreased expression of MX2 mRNA
CTD
PMID:33789219
NCBI chr11:36,905,698...36,936,308
Ensembl chr11:36,906,111...36,930,342
G
Nfil3
nuclear factor, interleukin 3 regulated
increases expression
EXP
bromuconazole results in increased expression of NFIL3 mRNA
CTD
PMID:33789219
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
EXP
bromuconazole results in increased expression of NR0B2 mRNA
CTD
PMID:33789219
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
decreases expression
EXP
bromuconazole results in decreased expression of NR1D1 mRNA
CTD
PMID:33789219
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr1d2
nuclear receptor subfamily 1, group D, member 2
decreases expression
EXP
bromuconazole results in decreased expression of NR1D2 mRNA
CTD
PMID:33789219
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
increases expression
EXP
bromuconazole results in increased expression of NR1H4 mRNA
CTD
PMID:33789219
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases expression multiple interactions
EXP ISO
bromuconazole results in increased expression of NR1I2 bromuconazole binds to and results in increased activity of NR1I2 protein
CTD
PMID:28532222 PMID:33049310
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
G
Nr1i3
nuclear receptor subfamily 1, group I, member 3
decreases expression
EXP
bromuconazole results in decreased expression of NR1I3
CTD
PMID:28532222
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
G
Pex5
peroxisomal biogenesis factor 5
increases expression
EXP
bromuconazole results in increased expression of PEX5 mRNA
CTD
PMID:33789219
NCBI chr 4:157,270,671...157,296,432
Ensembl chr 4:157,270,672...157,296,431
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions decreases expression
ISO EXP
bromuconazole binds to and results in increased activity of PPARG protein bromuconazole results in decreased expression of PPARG protein
CTD
PMID:33049310 PMID:33789219
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Prkar2a
protein kinase cAMP-dependent type II regulatory subunit alpha
increases expression
EXP
bromuconazole results in increased expression of PRKAR2A mRNA
CTD
PMID:33789219
NCBI chr 8:109,393,189...109,458,832
Ensembl chr 8:109,395,833...109,455,628
G
Rn7sl1
RNA component of signal recognition particle 7SL1
decreases expression
EXP
bromuconazole results in decreased expression of RN7SL1 mRNA
CTD
PMID:33789219
NCBI chr 6:87,636,808...87,637,106
Ensembl chr 6:87,636,804...87,637,103
G
Rorc
RAR-related orphan receptor C
increases expression
EXP
bromuconazole results in increased expression of RORC mRNA
CTD
PMID:33789219
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
G
Sesn2
sestrin 2
increases expression
EXP
bromuconazole results in increased expression of SESN2 mRNA
CTD
PMID:33789219
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
G
Slc28a2
solute carrier family 28 member 2
decreases expression
EXP
bromuconazole results in decreased expression of SLC28A2 mRNA
CTD
PMID:33789219
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
G
Slfn4
schlafen family member 4
decreases expression
EXP
bromuconazole results in decreased expression of SLFN4 mRNA
CTD
PMID:33789219
NCBI chr10:67,994,601...68,018,141
Ensembl chr10:68,000,028...68,018,138 Ensembl chr10:68,000,028...68,018,138
G
Tp53
tumor protein p53
increases expression
EXP
bromuconazole results in increased expression of TP53 mRNA
CTD
PMID:36370923
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
increases expression
EXP
bromuconazole results in increased expression of UGT2B1 mRNA
CTD
PMID:33789219
NCBI chr14:21,024,035...21,035,784
Ensembl chr14:21,024,006...21,035,986
G
Ugt2b7
UDP glucuronosyltransferase family 2 member B7
increases expression
EXP
bromuconazole results in increased expression of UGT2B7 mRNA
CTD
PMID:33789219
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
G
Wdr6
WD repeat domain 6
increases expression
EXP
bromuconazole results in increased expression of WDR6 mRNA
CTD
PMID:33789219
NCBI chr 8:109,268,079...109,274,504
Ensembl chr 8:109,268,079...109,274,499
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all